Public Release Type:
Journal
Publication Year: 2013
Authors:
Boyett SL,
Chalasani NP,
Guy CD,
Kohli R,
Luketic VA,
Puri P,
Sanyal AJ,
Sargeant C,
Siddiqui MS,
Unalp-Arida A,
Yates KP
Studies:
Nonalcoholic Steatohepatitis Clinical Research Network
Nonalcoholic steatohepatitis (NASH) is associated with increased risk of type 2 diabetes, insulin resistance and pancreatic β cell failure. It is not known if resolution of steatohepatitis is associated with improved β cell function.